Stalenhoef AF - Search Results

1

The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia.

van der Vleuten GM, Isaacs A, Hijmans A, van Duijn CM, Stalenhoef AF, de Graaf J. van der Vleuten GM, et al. Among authors: stalenhoef af. J Lipid Res. 2007 Jan;48(1):193-200. doi: 10.1194/jlr.M600184-JLR200. Epub 2006 Oct 25. J Lipid Res. 2007. PMID: 17065663 Free article.

2

Role of insulin resistance in familial combined hyperlipidemia.

Veerkamp MJ, de Graaf J, Stalenhoef AF. Veerkamp MJ, et al. Among authors: stalenhoef af. Arterioscler Thromb Vasc Biol. 2005 May;25(5):1026-31. doi: 10.1161/01.ATV.0000160612.18065.29. Epub 2005 Feb 24. Arterioscler Thromb Vasc Biol. 2005. PMID: 15731490

3

The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia.

van der Vleuten GM, Kluijtmans LA, Hijmans A, Blom HJ, Stalenhoef AF, de Graaf J. van der Vleuten GM, et al. Among authors: stalenhoef af. Int J Obes (Lond). 2006 Jun;30(6):892-8. doi: 10.1038/sj.ijo.0803234. Int J Obes (Lond). 2006. PMID: 16432543

4

Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.

Veerkamp MJ, de Graaf J, Hendriks JC, Demacker PN, Stalenhoef AF. Veerkamp MJ, et al. Among authors: stalenhoef af. Circulation. 2004 Jun 22;109(24):2980-5. doi: 10.1161/01.CIR.0000130646.93255.86. Epub 2004 Jun 7. Circulation. 2004. PMID: 15184285 Free article.

5

Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia.

van der Vleuten GM, Hijmans A, Kluijtmans LA, Blom HJ, Stalenhoef AF, de Graaf J. van der Vleuten GM, et al. Among authors: stalenhoef af. Am J Med Genet A. 2004 Sep 15;130A(1):73-5. doi: 10.1002/ajmg.a.30036. Am J Med Genet A. 2004. PMID: 15368498

6

Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia.

de Graaf J, van der Vleuten G, Stalenhoef AF. de Graaf J, et al. Among authors: stalenhoef af. Semin Vasc Med. 2004 Aug;4(3):229-40. doi: 10.1055/s-2004-861490. Semin Vasc Med. 2004. PMID: 15630632 Review.

7

Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile.

van der Vleuten GM, van Tits LJ, den Heijer M, Lemmers H, Stalenhoef AF, de Graaf J. van der Vleuten GM, et al. Among authors: stalenhoef af. J Lipid Res. 2005 Nov;46(11):2398-404. doi: 10.1194/jlr.M500212-JLR200. Epub 2005 Aug 16. J Lipid Res. 2005. PMID: 16106049 Free article.

8

Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD.

van der Vleuten GM, Veerkamp MJ, van Tits LJ, Toenhake H, den Heijer M, Stalenhoef AF, de Graaf J. van der Vleuten GM, et al. Among authors: stalenhoef af. Atherosclerosis. 2005 Dec;183(2):355-60. doi: 10.1016/j.atherosclerosis.2005.03.019. Atherosclerosis. 2005. PMID: 16285998

9

Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.

van der Vleuten GM, Isaacs A, Zeng WW, ter Avest E, Talmud PJ, Dallinga-Thie GM, van Duijn CM, Stalenhoef AF, de Graaf J. van der Vleuten GM, et al. Among authors: stalenhoef af. Biochim Biophys Acta. 2007 Jan;1772(1):81-8. doi: 10.1016/j.bbadis.2006.10.012. Epub 2006 Oct 26. Biochim Biophys Acta. 2007. PMID: 17157483 Free article.

10

High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia.

de Graaf J, van der Vleuten GM, ter Avest E, Dallinga-Thie GM, Stalenhoef AF. de Graaf J, et al. Among authors: stalenhoef af. J Clin Endocrinol Metab. 2007 Apr;92(4):1269-75. doi: 10.1210/jc.2006-1973. Epub 2007 Jan 16. J Clin Endocrinol Metab. 2007. PMID: 17227806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

344 results

Search Page